본문으로 건너뛰기
← 뒤로

Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata.

무작위 임상시험 4/5 보강
Journal of the American Academy of Dermatology 📖 저널 OA 27.4% 2021: 51/103 OA 2022: 38/93 OA 2023: 34/109 OA 2024: 41/104 OA 2025: 36/165 OA 2026: 23/194 OA 2021~2026 1987 Vol.16(3 Pt 2) p. 730-6 피인용 7회 cited 130 RCR 3.60 Hair Growth and Disorders
TL;DR Minoxidil applications were generally well tolerated except for three instances of scalp itching and dermatitis, two of which necessitated discontinuing the medication, and examination of vital signs and laboratory measurements revealed no evidence of systemic effects.
Retraction 확인
출처
PubMed DOI OpenAlex Semantic 마지막 보강 2026-05-10

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
환자: extensive patchy alopecia areata had greater than 50% scalp hair loss
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Examination of vital signs and laboratory measurements revealed no evidence of systemic effects of minoxidil. Seven of the twelve subjects assayed in the minoxidil group had detectable minoxidil serum levels, ranging from 0.4 to 7.5 ng/ml.
📑 코퍼스 인용 관계 · 인용됨 7
📑 인용한 논문 (6) ▾
연도별 인용 (2012–2025) · 합계 68
OpenAlex 토픽 · Hair Growth and Disorders Wound Healing and Treatments Dermatologic Treatments and Research

Price VH

📝 환자 설명용 한 줄

Minoxidil applications were generally well tolerated except for three instances of scalp itching and dermatitis, two of which necessitated discontinuing the medication, and examination of vital signs

이 논문을 인용하기

↓ .bib ↓ .ris
APA Vera H. Price (1987). Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata.. Journal of the American Academy of Dermatology, 16(3 Pt 2), 730-6. https://doi.org/10.1016/s0190-9622(87)70095-4
MLA Vera H. Price. "Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata.." Journal of the American Academy of Dermatology, vol. 16, no. 3 Pt 2, 1987, pp. 730-6.
PMID 3549809 ↗

Abstract

The safety and efficacy of 3% topical minoxidil were evaluated in the treatment of extensive patchy alopecia areata, alopecia totalis, and alopecia universalis. Patients with extensive patchy alopecia areata had greater than 50% scalp hair loss. In this double-blind study, thirty subjects applied minoxidil or placebo to half of the afflicted scalp area twice daily, with overnight petrolatum occlusion, for 1 year. Both male and female subjects, ranging in age from 9 to 65 years, were enrolled, fifteen subjects to each treatment group. Minoxidil applications were generally well tolerated except for three instances of scalp itching and dermatitis, two of which necessitated discontinuing the medication. Hair growth was seen in seven of eleven evaluable subjects (63.6%) in the minoxidil group and in five of fourteen evaluable subjects (35.7%) in the placebo group. Excellent, cosmetically acceptable hair growth was seen in three of eleven minoxidil-treated subjects (27.3%) and in one of fourteen placebo-treated subjects (7.1%). Examination of vital signs and laboratory measurements revealed no evidence of systemic effects of minoxidil. Seven of the twelve subjects assayed in the minoxidil group had detectable minoxidil serum levels, ranging from 0.4 to 7.5 ng/ml.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

인용 관계

그래프 OA 노드: 5/7 (71%) · 참조 0편 · 후속 5편

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반